These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8503727)

  • 21. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
    Chng WJ; Sum C; Kuperan P
    Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Activated Seven Lupus Anticoagulant (ASLA) test has comparable sensitivity to classical assays for screening of lupus anticoagulant.
    Marinuzzo M; Adamczuk Y; Varela ML; Pombo G; Forastiero R
    Thromb Haemost; 2005 May; 93(5):1007-9. PubMed ID: 15900652
    [No Abstract]   [Full Text] [Related]  

  • 23. The tissue thromboplastin inhibition test in the detection of lupus anticoagulants: importance of a correction factor eliminating the influence of fibrinogen level.
    Eschwège V; Seddiki S; Robert A
    Thromb Haemost; 1996 Jul; 76(1):65-8. PubMed ID: 8819253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged activated partial thromboplastin time in patients with antiphospholipid antibody syndrome.
    Dyer JR; Raj T
    Anesth Analg; 2006 Dec; 103(6):1586-7; author reply 1587-8. PubMed ID: 17122253
    [No Abstract]   [Full Text] [Related]  

  • 25. Lupus anticoagulant and factor XII activity in children with prolonged PTT.
    Edlinger G; Gallistl S; Muntean W
    Thromb Res; 1996 Sep; 83(5):403-4. PubMed ID: 8873349
    [No Abstract]   [Full Text] [Related]  

  • 26. Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force.
    J Clin Pathol; 1991 Nov; 44(11):885-9. PubMed ID: 1752976
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of lupus anticoagulant: an evaluation of routines for preparation and storage of plasma.
    Schjetlein R; Wisløff F
    Thromb Res; 1995 Jul; 79(1):135-40. PubMed ID: 7495101
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevalence of prolonged APTT and lupus anticoagulant in autoimmune thyroid disease].
    Tani Y; Morita M; Noguchi S
    Rinsho Byori; 1997 Sep; 45(9):899-902. PubMed ID: 9311265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers.
    Lawrie AS; Mackie IJ; Purdy G; Machin SJ
    Thromb Haemost; 1999 May; 81(5):758-62. PubMed ID: 10365750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The preparation of a sensitive partial thromboplastin reagent from bovine brain.
    Martin BA; Branch DW; Rodgers GM
    Blood Coagul Fibrinolysis; 1992 Jun; 3(3):287-94. PubMed ID: 1643206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lupus-like circulating anticoagulant or antifactor? Preoperative difficult diagnosis].
    Martin-Toutain I; Vu T; Azgui Z; Piot MT; Jung M; Ankri A
    Ann Biol Clin (Paris); 2004; 62(4):451-5. PubMed ID: 15297241
    [No Abstract]   [Full Text] [Related]  

  • 33. The lupus anticoagulant. High incidence of 'negative' mixing studies in a human immunodeficiency virus-positive population.
    Clyne LP; Yen Y; Kriz NS; Breitenstein MG
    Arch Pathol Lab Med; 1993 Jun; 117(6):595-601. PubMed ID: 8503730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of lupus anticoagulant in multiparous women in Benin City, Nigeria.
    Awodu OA; Ejele OA; Shokunbi WA; Enosolease ME
    Niger Postgrad Med J; 2003 Mar; 10(1):19-22. PubMed ID: 12812147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests.
    Zhang L; Whitis JG; Embry MB; Hollensead SC
    Am J Clin Pathol; 2005 Dec; 124(6):894-901. PubMed ID: 16416739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lupus anticoagulants: pathogenesis and laboratory diagnosis.
    Court EL
    Br J Biomed Sci; 1997 Dec; 54(4):287-98. PubMed ID: 9624740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 2-year retrospective analysis of laboratory testing for activated protein C resistance with a factor V-corrected activated partial thromboplastin time-based method.
    De Bel AV; Van der Cruyssen GA; Devreese KM
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):155-60. PubMed ID: 16479199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The detection of lupus anticoagulant using the kaolin clotting time test: a comparative study of the different forms of analysis.
    Forero Y; Escobar J; Vernot JP
    Thromb Res; 1995 Aug; 79(3):289-96. PubMed ID: 8533124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The lupus anticoagulant: report of a case.
    Barber K; Freed N; Proebstle P; Biondi R
    J Am Osteopath Assoc; 1983 May; 82(9):669-73. PubMed ID: 6408034
    [No Abstract]   [Full Text] [Related]  

  • 40. Activated protein C resistance and lupus anticoagulant in pregnancy.
    Busowski JD; Jenkins AD; Hale EU; Busowski M; Dacus JV
    J Matern Fetal Med; 1999; 8(6):298-9. PubMed ID: 10582865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.